Search research articles
Contact Us
Filters
Showing results (81-90 of 113) with videos related to
Page
of 12
Sort By:
Ejhaem
|
August 22, 2025
Disease Activity After Switching From Eculizumab to Ravulizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria: Real World Data From Denmark and Finland
Anders Rønneholt-Frederiksen, Dennis Lund Hansen, Vuokko Nummi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 16, 2000
Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer co-operative Group DBCG 82B Trial
M Andersson, C Kamby, M B Jensen, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1988
Adjuvant therapy of premenopausal and menopausal high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group Trials 77-B and 82-B
P Dombernowsky, H Brincker, M Hansen, et al.
Journal of Clinical and Translational Science
|
February 16, 2026
Erratum: 355 Validation of an artificial intelligence Algorithm for predicting diagnosis-related groups in a community health system - CORRIGENDUM
Angela Muhanga, Jason King, Jennifer L Mueller, et al.
Ugeskrift for Laeger
|
August 12, 1991
[Adjuvant endocrine treatment of postmenopausal patients with breast cancer with high risk of recurrence. 5. Results from the DBCG (Danish Breast Cancer Cooperative Group) 77C randomized trial]
C Rose, J A Andersen, K W Andersen, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1988
A Danish randomized trial comparing breast-preserving therapy with mastectomy in mammary carcinoma. Preliminary results
M Blichert-Toft, H Brincker, J A Andersen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 1, 1990
Evaluation of radiotherapy in high-risk breast cancer patients: report from the Danish Breast Cancer Cooperative Group (DBCG 82) Trial
M Overgaard, J J Christensen, H Johansen, et al.
The New England Journal of Medicine
|
February 12, 1998
Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial
M Overgaard, P S Hansen, J Overgaard, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
March 24, 2025
Screening for pre-eclampsia using pregnancy-associated plasma protein-A or placental growth factor measurements in blood samples collected at 8-14 weeks' gestation
L Rode, A Wright, D Wright, et al.
Ugeskrift for Laeger
|
August 12, 1991
[Adjuvant chemotherapy in premenopausal and menopausal high-risk patients with breast cancer. 4. Results of the DBCG (Danish Breast Cancer Cooperative Group) 77B study]
P Dombernowsky, J A Andersen, K W Andersen, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 113) with videos related to
Sort By:
Page
of 12
Ejhaem
|
August 22, 2025
Disease Activity After Switching From Eculizumab to Ravulizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria: Real World Data From Denmark and Finland
Anders Rønneholt-Frederiksen, Dennis Lund Hansen, Vuokko Nummi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 16, 2000
Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer co-operative Group DBCG 82B Trial
M Andersson, C Kamby, M B Jensen, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1988
Adjuvant therapy of premenopausal and menopausal high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group Trials 77-B and 82-B
P Dombernowsky, H Brincker, M Hansen, et al.
Journal of Clinical and Translational Science
|
February 16, 2026
Erratum: 355 Validation of an artificial intelligence Algorithm for predicting diagnosis-related groups in a community health system - CORRIGENDUM
Angela Muhanga, Jason King, Jennifer L Mueller, et al.
Ugeskrift for Laeger
|
August 12, 1991
[Adjuvant endocrine treatment of postmenopausal patients with breast cancer with high risk of recurrence. 5. Results from the DBCG (Danish Breast Cancer Cooperative Group) 77C randomized trial]
C Rose, J A Andersen, K W Andersen, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1988
A Danish randomized trial comparing breast-preserving therapy with mastectomy in mammary carcinoma. Preliminary results
M Blichert-Toft, H Brincker, J A Andersen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 1, 1990
Evaluation of radiotherapy in high-risk breast cancer patients: report from the Danish Breast Cancer Cooperative Group (DBCG 82) Trial
M Overgaard, J J Christensen, H Johansen, et al.
The New England Journal of Medicine
|
February 12, 1998
Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial
M Overgaard, P S Hansen, J Overgaard, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
March 24, 2025
Screening for pre-eclampsia using pregnancy-associated plasma protein-A or placental growth factor measurements in blood samples collected at 8-14 weeks' gestation
L Rode, A Wright, D Wright, et al.
Ugeskrift for Laeger
|
August 12, 1991
[Adjuvant chemotherapy in premenopausal and menopausal high-risk patients with breast cancer. 4. Results of the DBCG (Danish Breast Cancer Cooperative Group) 77B study]
P Dombernowsky, J A Andersen, K W Andersen, et al.
Page
of 12